5 hours ago
1
tonefotografia/iStock via Getty Images
I-Mab (NASDAQ:IMAB) said on Thursday that it has signed an agreement to acquire Bridge Health Biotech.
As part of the deal, I-Mab will provide an initial payment of $1.8M to Bridge Health shareholders, along with additional payments totaling $1.2M scheduled through 2027.
English (US) ·